MENU
PEPG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

PepGen (PEPG) Ownership - Who owns PepGen?

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases... Show more

Profile

Industry
N/A
Address
321 Harrison Avenue
Phone
+1 781 797-0979
Employees
64
Web
https://www.pepgen.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
397.36M
P/E Ratio
N/A
Total Cash
163.67M
Projected Growth
N/A
Total Debt
17.44M
Revenue
N/A
Risk (Beta)
1.84
Dividend Yield
N/A
Total Cash/Share
2.38
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

PEPG
Capitalization
397M
P/E Ratio
N/A
Risk (Beta)
1.84
Dividend Yield
N/A
Total Cash
164M
Total Cash/Share
2.38
Total Debt
17.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
163M
P/B Ratio
2.44
Cash Flow
N/A
Earnings
-2.82
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
13.15
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-93.06M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-51.93
Shares Held By Institutions
613M
Shares Outstanding - Current
68.7M
Total Liabilities
26.9M
Total Volume MTD
N/A
Value
1
Gain YTD
40.897
View a ticker or compare two or three
PEPG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PEPG showed earnings on November 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 781 797-0979
Employees
64
Web
https://www.pepgen.com